Zacks Investment Management’s Medifast MED Stock Holding History

Zacks Investment Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,467	Closed	-$517K	–	630
2021 Q4	$517K	Sell	2,467 -769	-24%	-$159K	0.01%	458
2021 Q3	$623K	Buy	3,236 +268	+9%	+$65.9K	0.01%	430
2021 Q2	$840K	Buy	+2,968	New	+$804K	0.01%	388
2019 Q4	–	Sell	-7,521	Closed	-$779K	–	566
2019 Q3	$779K	Sell	7,521 -498	-6%	-$53.5K	0.02%	404
2019 Q2	$1.03M	Sell	8,019 -328	-4%	-$45.6K	0.02%	391
2019 Q1	$1.06M	Buy	8,347 +1,160	+16%	+$147K	0.02%	385
2018 Q4	$899K	Sell	7,187 -2,319	-24%	-$397K	0.02%	363
2018 Q3	$2.11M	Sell	9,506 -157	-2%	-$31.8K	0.04%	263
2018 Q2	$1.55M	Buy	+9,663	New	+$1.24M	0.03%	338
2016 Q4	–	Sell	-6,124	Closed	-$231K	–	691
2016 Q3	$231K	Buy	+6,124	New	+$220K	0.01%	545

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Zacks Investment Management's MED Position: Q1 2022 in Review

Zacks Investment Management sold out of Medifast (MED) in Q1 2022, closing a stake of 2,467 shares — an estimated $517K sold.

Zacks Investment Management first reported a position in MED in Q3 2016 and held it in 10 quarters. The position peaked at $2.11M in Q3 2018. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

Zacks Investment Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
Zacks Investment Management sold 2,467 Medifast shares in Q1 2022, an estimated $517K.
Zacks Investment Management first reported a position in Medifast in Q3 2016 and held it in 10 quarters.
Zacks Investment Management's Medifast position peaked at $2.11M in Q3 2018.
288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Zacks Investment Management's 13F filing for Q1 2022, filed 13 May 2022.